Develops novel therapeutics to treat diseases of the eye

$14.13  -0.73 (-4.91%)
As of 12/03/2021 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/18/2018
Outstanding shares:  114,641,279
Average volume:  1,271,638
Market cap:   $1,703,569,406
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    46583P102
ISIN:        US46583P1021
Sedol:      BK8Y8K9
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   6.49
PS ratio:   0.00
Return on equity:   -47.21%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy